Phio Pharmaceuticals (PHIO) Revenue (2016 - 2019)
Phio Pharmaceuticals' Revenue history spans 8 years, with the latest figure at $21000.0 for Q1 2019.
- For Q1 2019, Revenue fell 8.7% year-over-year to $21000.0; the TTM value through Dec 2019 reached $21000.0, down 84.78%, while the annual FY2024 figure was $250000.0, 2677.78% up from the prior year.
- Revenue reached $21000.0 in Q1 2019 per PHIO's latest filing, down from $57000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $58000.0 in Q2 2018 to a low of $9000.0 in Q2 2016.
- Average Revenue over 5 years is $28375.0, with a median of $22000.0 recorded in 2018.
- Peak YoY movement for Revenue: increased 17.24% in 2015, then tumbled 70.59% in 2016.
- A 5-year view of Revenue shows it stood at $34000.0 in 2015, then plummeted by 73.53% to $9000.0 in 2016, then surged by 66.67% to $15000.0 in 2017, then skyrocketed by 280.0% to $57000.0 in 2018, then plummeted by 63.16% to $21000.0 in 2019.
- Per Business Quant, the three most recent readings for PHIO's Revenue are $21000.0 (Q1 2019), $57000.0 (Q3 2018), and $58000.0 (Q2 2018).